Evidence map›Paper›PMID 30693065›Full record

ArticleOxidative medicine and cellular longevity2018

Computational Studies Applied to Flavonoids against Alzheimer's and Parkinson's Diseases.

Alex France M Monteiro, Jéssika De O Viana, Anuraj Nayarisseri, Ernestine N Zondegoumba, Francisco Jaime B Mendonça Junior, Marcus Tullius Scotti, Luciana Scotti

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 93 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Evidence of Flavonoids on Disease Prevention.Antioxidants (Basel, Switzerland) · 2023
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 4 countries.

Alex France M MonteiroPostgraduate Program in Natural and Synthetic Bioactive Products, Federal University of Paraíba, João Pessoa, PB, Brazil.
Jéssika De O VianaPostgraduate Program in Natural and Synthetic Bioactive Products, Federal University of Paraíba, João Pessoa, PB, Brazil.
Anuraj NayarisseriIn Silico Research Laboratory, Eminent Bioscience, Inodre - 452010, Madhya Pradesh, India.
Ernestine N ZondegoumbaDepartment of Organic Chemistry, Faculty of Science, University of Yaounde I, PO Box 812, Yaoundé, Cameroon.ORCID 0000-0001-5533-548X
Francisco Jaime B Mendonça JuniorLaboratory of Synthesis and Drug Delivery, Department of Biological Science, State University of Paraiba, João Pessoa, PB, Brazil.ORCID 0000-0003-3588-833X
Marcus Tullius ScottiPostgraduate Program in Natural and Synthetic Bioactive Products, Federal University of Paraíba, João Pessoa, PB, Brazil.ORCID 0000-0003-4863-8057
Luciana ScottiPostgraduate Program in Natural and Synthetic Bioactive Products, Federal University of Paraíba, João Pessoa, PB, Brazil.ORCID 0000-0003-1866-4107
Universidade Federal da Paraíba · BRIn Silico Biosciences (United States) · USUniversidade Estadual da Paraíba · BRUniversité de Yaoundé I · CM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurodegenerative diseases, such as Parkinson's and Alzheimer's, are understood as occurring through genetic, cellular, and multifactor pathophysiological mechanisms. Several natural products such as flavonoids have been reported in the literature for having the capacity to cross the blood-brain barrier and slow the progression of such diseases. The present article reports on

Indexed as

Computer SimulationMolecular Docking SimulationAlzheimer DiseaseDatabases, FactualFlavonoidsHumansModels, MolecularNeuroprotective AgentsParkinson DiseaseProtein ConformationQuantitative Structure-Activity RelationshipFlavonoidsNeuroprotective Agents

Identifiers

PMID30693065
PMCPMC6332933
OpenAlexW2908107835

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.